CHEST 2021 Annual Meeting

Complete Coverage

Hospitalization Rates Stable, But Diabetes Less Common, Among PAH Patients

The hospitalization rate and in-hospital mortality among patients with pulmonary arterial hypertension (PAH) seem to be stable in the US, according to a new study published in the journal Chest and presented at the Chest 2021 Annual Meeting. However, the proportion of diabetes among these patients seems to have decreased. Studies conducted before 2013 suggested…

Study Suggests PAH Patients Need Special Attention During Intubation

Mechanically ventilated pulmonary arterial hypertension (PAH) patients have a worse outcome than similar patients without PAH, according to a study published in Chest and presented at the Chest 2021 Annual Meeting. The researchers also reported that the first 24 hours after intubation is a particularly vulnerable period that may be crucial for the long-term outcomes…

New Genetic Polymorphism May Increase Risk of IPF

There may be an association between the MUC5B rs35705950 T allele and the risk of developing idiopathic pulmonary fibrosis (IPF), according to a new study published in the journal Chest and presented at the Chest 2021 Annual Meeting. Genetic screening could play a key role in a population whose members have a family history of IPF.…

Patients With IPF and GERD Showed Higher Risk for Poor Outcomes

There is an association between idiopathic pulmonary fibrosis (IPF) and gastroesophageal reflux disease (GERD), according to results published in Chest. The study is being presented virtually at the Chest 2021 Annual Meeting on Oct. 17-20, 2021. The association between IPF and GERD was already known possibly due to chronic micro-aspiration leading to lung parenchyma remodeling.…

Importance of AATD Patients Recognizing Exacerbations in Pulmonary Symptoms

Changes in usual lung symptoms are not universally recognized as exacerbations, according to a new study published in the journal Chest and being presented at the Chest 2021 Annual Meeting. The correlation between symptom-based exacerbation and the definition of an exacerbation based on health care utilization is not high.  Identifying pulmonary exacerbations in patients with…
IPF exercise

Dedicated ILD Clinic Care Improves the Monitoring of Patients With IPF

A dedicated interstitial lung disease (ILD) clinic improves the care provided to patients with idiopathic pulmonary fibrosis (IPF), according to a recent study conducted by Gross et al. Improvements were observed even in clinics located in small healthcare systems, regardless of their association with a tertiary care center. The results of the study will be…

AATD Testing in COPD Patients Remains Low Despite Clinical Benefits

Are we testing enough for alpha-1 antitrypsin deficiency (AATD) in patients who develop chronic obstructive pulmonary disease (COPD)? Rao and colleagues set out to investigate the answer to this question. They discovered that only 20.6% of COPD patients underwent AATD testing, despite the majority of physicians demonstrating awareness of the importance to test all newly…

Rare Pancreatic Tumors Could Be a Comorbidity in Patients With PAH

Intraductal papillary mucinous neoplasms (IPMNs) could increasingly be seen as a comorbidity in patients with pulmonary arterial hypertension (PAH), especially as their life expectancy increases. This is according to a new case study published in the Chest journal and being presented at the Chest 2021 Annual Meeting. More research is needed to see whether the…

CHEST 2021

Rare Disease Advisor is pleased to offer live coverage of the 2021 CHEST Annual Meeting. This year, CHEST is hosting a fully virtual event that features over 200+ sessions as well as a host of interactive experiences and opportunities for clinicians, researchers, and other stakeholders.

RDA is offering coverage of several specific rare pulmonary diseases, including idiopathic pulmonary fibrosis (IPF), pulmonary arterial hypertension (PAH), and alpha-1 antitrypsin deficiency (AATD). Be sure to tune in to our live coverage, which will run through the weekend.

Follow our sister website, Pulmonology Advisor, for additional coverage of CHEST 2021 in other disease areas.

Next post in PAH News Briefs